World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
22441
World Ranking
17161
National Ranking
8600

John D. Pirsch publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John D. Pirsch sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 270 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John D. Pirsch D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John D. Pirsch sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

John D. Pirsch is affiliated with the University of Wisconsin-Madison in the United States. Their research primarily focuses on fields within medicine, including biochemistry, genetics, and molecular biology, with specific subfields in rheumatology, clinical biochemistry, and transplantation.

The scientist's work covers several main topics:

  • Folate and B Vitamins Research
  • Metabolism and Genetic Disorders
  • Renal Transplantation Outcomes and Treatments

Among their recent published work is the paper titled "Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results From the Folic Acid for Vascular Outcome Reduction in Transplantation Trial", published in 2020 in UNC Libraries. This publication has been cited 13 times.

Frequent coauthors collaborating with John D. Pirsch include:

  • Andrew G. Bostom
  • Myra A. Carpenter
  • John W. Kusek
  • Andrew S. Levey
  • Lawrence G. Hunsicker

The primary venue for their publications includes:

  • UNC Libraries

Best Publications

  • A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

    John D. Pirsch;Joshua Miller;Mark H. Deierhoi;Flavio Vincenti

  • Risk factors for primary dysfunction after liver transplantation--a multivariate analysis.

    Rutger Ploeg;Anthony D'alessandro;Stuart Knechtle;Mark Stegall

  • K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease

    Andrew S. Levey;Michael V. Rocco;Sharon Anderson;Sharon P. Andreoli

  • The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation.

    Anthony M. D'alessandro;Munci Kalayoglu;Hans W. Sollinger;Robert M. Hoffmann

  • A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy

    E. Steve Woodle;M. Roy First;John Pirsch;Fuad Shihab

  • A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years.

    Flavio Vincenti;Stephen C. Jensik;Ronald S. Filo;Joshua Miller

  • Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients

    Mark D. Pescovitz;John Rabkin;Robert M. Merion;Carlos V. Paya

  • Campath‐1H Induction Plus Rapamycin Monotherapy for Renal Transplantation: Results of a Pilot Study

    Stuart J. Knechtle;John D. Pirsch;John H. Fechner;Bryan N. Becker

  • The Effect of Tolerance to Noninherited Maternal HLA Antigens on the Survival of Renal Transplants from Sibling Donors

    W.J. Burlingham;A.P. Grailer;D.M. Heisey;F.H.J. Claas

  • Prednisone withdrawal, in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study

    Nasimul Ahsan;Donald E Hricik;Arthur Matas;Stephen Rose

  • Rituximab as Treatment for Refractory Kidney Transplant Rejection

    Yolanda T. Becker;Bryan N. Becker;John D. Pirsch;Hans W. Sollinger

  • A systematic review of kidney transplantation from expanded criteria donors.

    Julio Pascual;Javier Zamora;John D. Pirsch

  • Experience with 500 simultaneous pancreas-kidney transplants.

    Hans W. Sollinger;Jon S. Odorico;Stuart J. Knechtle;Anthony M. D'Alessandro

  • One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up.

    Hans W Sollinger;Jon S Odorico;Yolanda T Becker;Anthony M D'Alessandro

  • Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results From the Folic Acid for Vascular Outcome Reduction in Transplantation Trial

    Andrew G. Bostom;Myra A. Carpenter;John W. Kusek;Andrew S. Levey

  • Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group

    Joshua Miller;Robert Mendez;John D. Pirsch;Stephen C. Jensik

  • Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease

    Bryan N. Becker;Peter C. Brazy;Yolanda T. Becker;Jon S. Odorico

  • Liver transplantation from controlled non-heart-beating donors.

    Anthony M. D'Alessandro;Robert M. Hoffmann;Stuart J. Knechtle;Jon S. Odorico

  • Clinical Utility of Monitoring Tacrolimus Blood Concentrations in Liver Transplant Patients

    Raman Venkataramanan;Leslie M. Shaw;Laszlo Sarkozi;Richard Mullins

  • Determinants of graft survival after renal transplantation.

    John D. Pirsch;Rutger J. Ploeg;Stephen Gange;Anthony M. D'Alessandro

Frequent Co-Authors

Hans W. Sollinger
Hans W. Sollinger University of Wisconsin–Madison
Stuart J. Knechtle
Stuart J. Knechtle Duke University
Angelo D'Alessandro
Angelo D'Alessandro University of Colorado Denver
Robert J. Stratta
Robert J. Stratta Wake Forest University
William J. Burlingham
William J. Burlingham University of Wisconsin–Madison
Rutger J. Ploeg
Rutger J. Ploeg University of Oxford
Mark D. Stegall
Mark D. Stegall Mayo Clinic
Allan D. Kirk
Allan D. Kirk Duke University
Julio Pascual
Julio Pascual University of Cantabria
Arthur J. Matas
Arthur J. Matas University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The medical field offers a broad range of online degree programs for those seeking flexible education and diverse career opportunities. Aspiring nurses can benefit from fast LPN program options, which allow students to begin their careers as Licensed Practical Nurses in less time than traditional routes. For those interested in furthering their nursing education, online dnp programs without clinicals offer a convenient path toward advanced practice and leadership, especially for registered nurses looking to balance work and study.

Mental health is a growing focus within the healthcare sector, and qualifying as a nurse practitioner is now more accessible through online psych np programs. These programs are designed for those passionate about psychiatric and mental health care. Meanwhile, individuals interested in the administrative side of healthcare can explore career advancement by pursuing a health administration degree online, ideal for managing hospitals and healthcare organizations. Each of these online pathways supports a variety of career goals within the US healthcare system, combining flexibility and accredited learning.

Best Scientists Citing John D. Pirsch

Recently Published Articles